Fifty years after ‘Asilomar,’ scientists meet again to debate biotech’s modern-day threats
By Jon Cohen,
Science
| 03. 05. 2025
Photo by Wonderlane on Unsplash
On a nearly still and moonlit night last week, some 75 people formed a circle on Asilomar State Beach around a sand pit ringed by seaweed. Four dancers swayed around the pit to the sound of the crashing waves. One by one, people stepped into the circle, scooped up some sand, and tossed it into the pit.
Passersby might have thought they were witnessing a pagan ritual or a hippie gathering. But in fact this was a “burial ceremony” at the start of a meeting marking the 50th anniversary of the Asilomar Conference on Recombinant DNA. Participants were invited to bid a symbolic farewell to that hugely influential gathering, held at the same place in 1975, and turn to the most vexing issues facing biology today.
Half a century ago, molecular biologists came together up the hill from the beach in a conference center—made up of exquisite Arts and Crafts buildings that date back to 1913—to discuss the benefits and dangers of what was then a revolutionary technique: stitching together DNA from different species, creating...
Related Articles
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Mike Baker, The New York Times | 02.25.2025
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students in the fall of 2022, they were focused on a key piece of evidence: DNA on a knife sheath that...